Alt5 Sigma Corporation (ALTS)

$ALTS so MSwipe deal fell through? They never said they closed it, but never said it was off. Very odd.

$ALTS Any thoughts on next week?

$ALTS Anyone else seeing a short squeeze setup here ? 🤔

$ALTS does anyone know if the mswipe transaction has closed

$ALTS Deep Dive https://youtu.be/KvXFGzOfAAY?si=nb2R--m62L7BCP3T

Anyone else feeling the buzz around $ALTS? Options are going wild, especially with that 63% OTM action. Looks like the big players are diving in with short expirations—definitely not your average trade. I can’t shake this feeling that something's up. Is it just noise, or do you think we’re on the verge of a surprise? Let’s keep our eyes peeled; could be an interesting ride ahead!

$ALTS board transition: Richard Butler's passing marks end of era, replaced by David Danziger - CPA with 40+ years auditing public companies. New audit chair inherits negative book value and cash burn. At $7.88/share grant price, market will decide if governance experience offsets structural challenges. https://www.sec.gov/Archives/edgar/data/862861/000162828025034268/jan-20250627.htm

$ALTS ⏳📈6️⃣0️⃣

🚨Final Watchlist - July 2nd Not every runner starts on the front page. These five setups are building quietly with real catalysts, low floats, and breakout charts that are nearly ready. If you're looking for early entries with high reward potential, this batch is loaded with opportunity. One catalyst, one volume burst - and any of these can lead the tape tomorrow. $ALTS – Russell index addition and stablecoin narrative, watch 7.96 breakout $FRSX – Multi-catalyst rail and drone tech play, squeezing under 0.528 $DGXX – Golden Cross alert and GPU AI deal, pressing 2.73 $GRYP – SEC filing confirms American Bitcoin uplisting, 59% move already $ASBP – Biotech catalyst chain nearly complete, volume building under 0.31 Each one has a real, unpriced catalyst and a chart that’s coiled under key resistance. Whether it's institutional flow from Russell adds (ALTS), high-conviction AI/crypto momentum (DGXX), biotech trial progress (ASBP), or an SEC-backed uplisting (GRYP), these setups are primed for fast upside if their levels break on volume. ALTS Targets: 8.20 / 8.65 / 9.27 Stop: 7.11 FRSX Targets: 0.552 / 0.589 / 0.638 Stop: 0.478 DGXX Targets: 2.90 / 3.15 / 3.45 Stop: 2.49 GRYP Targets: 1.68 / 1.87 / 2.11 Stop: 1.32 ASBP Targets: 0.34 / 0.38 / 0.42 Stop: 0.261

$ALTS ALT5 Sigma Corporation Added to the Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index